Search Within

Neha Sanat Korde

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Meeting Abstract (3)
  2. Journal Article (2)
Groups
  1. Bone Marrow Transplant (5)
  2. CTCR Scholars (5)
  3. Center for Hematologic Malignancies (5)
  4. Department of Medicine (5)
  5. Epidemiology and Biostatistics (5)
  6. Hematologic Malignancies Research (5)

More Groups

People
  1. Alexander Lesokhin (5)
  2. David Chung (5)
  3. Gunjan Shah (5)
  4. Hani Hassoun (5)
  5. Heather Landau (5)
  6. Malin Hultcrantz (5)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2021 (1)
  4. 2020 (2)
Publications
  1. Blood (2)
  2. Clinical Lymphoma, Myeloma and Leukemia (1)
  3. Journal of Clinical Oncology (1)
  4. Nature Communications (1)
Publishers
  1. American Society of Hematology (2)
  2. American Society of Clinical Oncology (1)
  3. Elsevier Inc. (1)
  4. Nature Publishing Group (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I trial of MCARH109, a G protein-coupled receptor class C group 5 member D (GPRC5D)-targeted chimeric antigen receptor T-cell therapy for multiple myeloma: An updated analysis
    Journal Article

    Jurgens, E. M.; Firestone, R. S.; Chaudhari, J.; Hosszu, K.; Devlin, S. M.; Shah, U. A.; Landa, J.; McAvoy, D. P.; Lesokhin, A. M.; Korde, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Phase I trial of MCARH109, a first-in-class G Protein Coupled Receptor Class C Group 5 Member D (GPRC5D)-targeted CAR T-cell therapy for relapsed or refractory multiple myeloma: Updated analysis
    Meeting Abstract

    Jurgens, E.; Firestone, R.; Chaudhari, J.; Hosszu, K.; Devlin, S.; Shah, U.; Landa, J.; McAvoy, D.; Lesokhin, A.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Phase I first-in-class trial of MCARH109, a G protein coupled receptor class C group 5 member D (GPRC5D) targeted CAR T cell therapy in patients with relapsed or refractory multiple myeloma
    Meeting Abstract

    Mailankody, S.; Diamonte, C.; Fitzgerald, L.; Kane, P.; Wang, X.; Sikder, D. S.; Senechal, B.; Bermudez, V. P.; Frias, D.; Morgan, J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • A pilot study evaluating lenalidomide and CC-486 in combination with radiotherapy for patients with plasmacytoma (LENAZART study)
    Meeting Abstract

    Shah, U. A.; Werner, K.; Tavitian, E.; Devlin, S.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Tan, C.; Lu, S. X.; Smith, E. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Accelerated single cell seeding in relapsed multiple myeloma
    Journal Article

    Landau, H. J.; Yellapantula, V.; Diamond, B. T.; Rustad, E. H.; Maclachlan, K. H.; Gundem, G.; Medina-Martinez, J.; Arango Ossa, J.; Levine, M. F.; Zhou, Y.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save